Blueprint Medicines Corporation (LON:0HOJ)

Blueprint Medicines Market Cap

Blueprint Medicines is not actively traded anymore. When Blueprint Medicines last traded, it had a market cap or net worth of $6.21 billion.

• Market Cap: 6.21B
• Enterprise Value: 6.07B
• Revenue: 435.08M
• Ranking: n/a
• PE Ratio: n/a
• Stock Price: 129.35

Market Cap Chart

Since April 30, 2015, Blueprint Medicines's market cap has increased from 317.21M to 6.21B, an increase of 1,856.14%. That is a compound annual growth rate of 33.76%.

Market Cap History

Date	Market Cap	% Change
Jul 17, 2025	6.25B	41.19%
Dec 31, 2024	4.43B	0.54%
Dec 29, 2023	4.40B	102.36%
Dec 30, 2022	2.18B	-53.26%
Dec 31, 2021	4.65B	1.67%
Dec 31, 2020	4.58B	53.82%